Literature DB >> 22911642

An outbreak of wild poliovirus in the Republic of Congo, 2010-2011.

Minal K Patel1, Mandy Kader Konde, Boris Hermann Didi-Ngossaki, Edouard Ndinga, Riziki Yogolelo, Mbaye Salla, Keith Shaba, Johannes Everts, Gregory L Armstrong, Danni Daniels, Cara Burns, Steve Wassilak, Mark Pallansch, Katrina Kretsinger.   

Abstract

BACKGROUND: The Republic of Congo has had no cases of wild poliovirus type 1 (WPV1) since 2000. In October 2010, a neurologist noted an abnormal number of cases of acute flaccid paralysis (AFP) among adults, which were later confirmed to be caused by WPV1.
METHODS: Those presenting with AFP underwent clinical history, physical examination, and clinical specimen collection to determine if they had polio. AFP cases were classified as laboratory-confirmed, clinical, or nonpolio AFP. Epidemiologic features of the outbreak were analyzed.
RESULTS: From 19 September 2010 to 22 January 2011, 445 cases of WPV1 were reported in the Republic of Congo; 390 cases were from Pointe Noire. Overall, 331 cases were among adults; 378 cases were clinically confirmed, and 64 cases were laboratory confirmed. The case-fatality ratio (CFR) was 43%. Epidemiologic characteristics differed among polio cases reported in Pointe Noire and cases reported in the rest of the Republic of Congo, including age distribution and CFR. The outbreak stopped after multiple vaccination rounds with oral poliovirus vaccine, which targeted the entire population.
CONCLUSIONS: This outbreak underscores the need to maintain high vaccination coverage to prevent outbreaks, the need to maintain timely high-quality surveillance to rapidly identify and respond to any potential cases before an outbreak escalates, and the need to perform ongoing risk assessments of immunity gaps in polio-free countries.

Entities:  

Mesh:

Year:  2012        PMID: 22911642      PMCID: PMC4663667          DOI: 10.1093/cid/cis714

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

1.  Influence of age and sex on susceptibility and clinical manifestations in poliomyelitis.

Authors:  L WEINSTEIN
Journal:  N Engl J Med       Date:  1957-07-11       Impact factor: 91.245

2.  Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens.

Authors:  W Allan Nix; M Steven Oberste; Mark A Pallansch
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

3.  Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription-PCR using degenerate primers and probes containing deoxyinosine residues.

Authors:  David R Kilpatrick; Chen-Fu Yang; Karen Ching; Annelet Vincent; Jane Iber; Ray Campagnoli; Mark Mandelbaum; Lina De; Su-Ju Yang; Allan Nix; Olen M Kew
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

4.  A comparison of the clinical features of poliomyelitis in adults and in children.

Authors:  L WEINSTEIN; A SHELOKOV; R SELTSER; G D WINCHELL
Journal:  N Engl J Med       Date:  1952-02-21       Impact factor: 91.245

5.  Progress toward interrupting wild poliovirus circulation in countries with reestablished transmission--Africa, 2009-2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-03-18       Impact factor: 17.586

6.  Poliomyelitis outbreak--Republic of the Congo, September 2010-February 2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-03-18       Impact factor: 17.586

7.  Type 1 wild poliovirus and putative enterovirus 109 in an outbreak of acute flaccid paralysis in Congo, October-November 2010.

Authors:  G Grard; J F Drexler; S Lekana-Douki; M Caron; A Lukashev; D Nkoghe; J P Gonzalez; C Drosten; E Leroy
Journal:  Euro Surveill       Date:  2010-11-25

8.  Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China.

Authors:  H M Liu; D P Zheng; L B Zhang; M S Oberste; M A Pallansch; O M Kew
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

9.  Outbreak of paralytic poliomyelitis in Albania, 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccination.

Authors:  D R Prevots; M L Ciofi degli Atti; A Sallabanda; E Diamante; R B Aylward; E Kakariqqi; L Fiore; A Ylli; H van der Avoort; R W Sutter; A E Tozzi; P Panei; N Schinaia; D Genovese; G Oblapenko; D Greco; S G Wassilak
Journal:  Clin Infect Dis       Date:  1998-02       Impact factor: 9.079

10.  Investigation of elevated case-fatality rate in poliomyelitis outbreak in Pointe Noire, Republic of Congo, 2010.

Authors:  Christopher J Gregory; Serigne Ndiaye; Minal Patel; Elisaphan Hakizamana; Kathleen Wannemuehler; Edouard Ndinga; Susan Chu; Pascal Talani; Katrina Kretsinger
Journal:  Clin Infect Dis       Date:  2012-08-21       Impact factor: 9.079

View more
  15 in total

1.  Phylogeny of imported and reestablished wild polioviruses in theDemocratic Republic of the Congo from 2006 to 2011.

Authors:  Nicksy Gumede; Jaume Jorba; Jagadish Deshpande; Mark Pallansch; Riziki Yogolelo; Jean Jacques Muyembe-Tamfum; Olen Kew; Marietjie Venter; Cara C Burns
Journal:  J Infect Dis       Date:  2014-11-01       Impact factor: 5.226

2.  Comparison of the Immunogenicity of Various Booster Doses of Inactivated Polio Vaccine Delivered Intradermally Versus Intramuscularly to HIV-Infected Adults.

Authors:  Stephanie B Troy; Diana Kouiavskaia; Julia Siik; Efrat Kochba; Hind Beydoun; Olga Mirochnitchenko; Yotam Levin; Nancy Khardori; Konstantin Chumakov; Yvonne Maldonado
Journal:  J Infect Dis       Date:  2015-01-07       Impact factor: 5.226

3.  Global polio perspective.

Authors:  M Steven Oberste; Howard L Lipton
Journal:  Neurology       Date:  2014-05-20       Impact factor: 9.910

4.  Seroprevalence of poliovirus antibodies before and after polio vaccine switch in 2012 and 2017 in Beijing.

Authors:  Juan Li; Zhujiazi Zhang; Herun Zhang; Maozhong Li; Xiaomei Li; Li Lu; Fang Huang; Jiang Wu
Journal:  Hum Vaccin Immunother       Date:  2020-07-23       Impact factor: 3.452

5.  Robustness against serum neutralization of a poliovirus type 1 from a lethal epidemic of poliomyelitis in the Republic of Congo in 2010.

Authors:  Jan Felix Drexler; Gilda Grard; Alexander N Lukashev; Liubov I Kozlovskaya; Sindy Böttcher; Gökhan Uslu; Johan Reimerink; Anatoly P Gmyl; Raphaël Taty-Taty; Sonia Etenna Lekana-Douki; Dieudonné Nkoghe; Anna M Eis-Hübinger; Sabine Diedrich; Marion Koopmans; Eric M Leroy; Christian Drosten
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

Review 6.  Progress toward global interruption of wild poliovirus transmission, 2010-2013, and tackling the challenges to complete eradication.

Authors:  Steven G F Wassilak; M Steven Oberste; Rudolph H Tangermann; Ousmane M Diop; Hamid S Jafari; Gregory L Armstrong
Journal:  J Infect Dis       Date:  2014-11-01       Impact factor: 5.226

7.  Assessment of attitudes towards adverse events following immunization with oral poliovirus vaccine: a pilot study among high school students of Kinshasa, the Democratic Republic of Congo.

Authors:  Léon Kinuani; Didier Bomene Nzolo; Michel Ntetani Aloni; Pavel Makolo; Nsengi Ntamabyaliro; Yves Lula Ntamba; Crispin Kazadi; Michel Nyembwe; Mathilde Bothale Ekila; Gauthier Kahunu Mesia
Journal:  Pathog Glob Health       Date:  2014-09-19       Impact factor: 2.894

8.  The role of older children and adults in wild poliovirus transmission.

Authors:  Isobel M Blake; Rebecca Martin; Ajay Goel; Nino Khetsuriani; Johannes Everts; Christopher Wolff; Steven Wassilak; R Bruce Aylward; Nicholas C Grassly
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-07       Impact factor: 11.205

9.  Challenges associated with the recent outbreaks of wild-type poliovirus in previously polio-free countries.

Authors:  Subhash C Arya; Nirmala Agarwal
Journal:  Hum Vaccin Immunother       Date:  2012-10-30       Impact factor: 3.452

10.  [Investigation and response to an outbreak of wild poliovirus in Kinshasa].

Authors:  Muriel Nzazi Nsambu; Léodegal Bazira; Tiekoura Coulibaly; Albert Mbule; Michèle Dramaix Wilmet; Joris Losimba Likwela
Journal:  Pan Afr Med J       Date:  2013-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.